Advertisement

Significance of Left Ventricular Ejection Time in Primary Mitral Regurgitation

      The optimal timing for mitral valve (MV) surgery in asymptomatic patients with primary mitral regurgitation (MR) remains controversial. We aimed at evaluating the relation between left ventricular ejection time (LVET) and outcome in patients with moderate or severe chronic primary MR because of prolapse. Clinical, Doppler echocardiographic, and outcome data prospectively collected from 302 patients (median age 61 [54 to 74] years, 34% women) with moderate or severe primary MR were analyzed. Patients were retrospectively stratified by quartiles of LVET. The primary end point of the study was the composite of need for MV surgery or all-cause mortality. During a median follow-up time of 66 (25th to 75th percentile, 33 to 95) months, 178 patients reached the primary end point. Patients in the lowest quartile of LVET (<260 ms) were at high risk for adverse events compared with those in the other quartiles of LVET (global p = 0.005), whereas the rate of events was similar for the other quartiles (p = NS for all). After adjustment for clinical predictors of outcome, including age, gender, history of atrial fibrillation, MR severity, and current recommended triggers for MV surgery in asymptomatic primary MR, LVET <260 ms was associated with an increased risk of events (adjusted hazard ratio 1.49, 95% confidence interval 1.03 to 2.16, p = 0.033). In conclusion, we observed that shorter LVET is associated with increased risk of adverse events in patients with moderate or severe primary MR because of prolapse. Further studies are required to investigate whether shorter LVET has a direct effect on outcomes or is solely a risk marker in primary MR.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lazam S
        • Vanoverschelde JL
        • Tribouilloy C
        • Grigioni F
        • Suri RM
        • Avierinos JF
        • de Meester C
        • Barbieri A
        • Rusinaru D
        • Russo A
        • Pasquet A
        • Michelena HI
        • Huebner M
        • Maalouf J
        • Clavel MA
        • Szymanski C
        • Enriquez-Sarano M
        MIDA (Mitral Regurgitation International Database) Investigators. Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter, international registry.
        Circulation. 2017; 135: 410-422
        • Otto CM
        • Nishimura RA
        • Bonow RO
        • Carabello BA
        • Erwin 3rd, JP
        • Gentile F
        • Jneid H
        • Krieger EV
        • Mack M
        • McLeod C
        • O'Gara PT
        • Rigolin VH
        • Sundt 3rd, TM
        • Thompson A
        • Toly C
        • Writing Committee Members
        2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines.
        J Am Coll Cardiol. 2021; 77 ([published correction appears in J Am Coll Cardiol 2021;77:1276]): 450-500
        • Vahanian A
        • Beyersdorf F
        • Praz F
        • Milojevic M
        • Baldus S
        • Bauersachs J
        • Capodanno D
        • Conradi L
        • De Bonis M
        • De Paulis R
        • Delgado V
        • Freemantle N
        • Gilard M
        • Haugaa KH
        • Jeppsson A
        • Jüni P
        • Pierard L
        • Prendergast BD
        • Sádaba JR
        • Tribouilloy C
        • Wojakowski W
        • ESC/EACTS Scientific Document Group
        2021 ESC/EACTS guidelines for the management of valvular heart disease.
        Eur Heart J. 2022; 43 ([published correction appears in Eur Heart J. 2022 Feb 18;:]): 561-632
        • Enriquez-Sarano M
        • Suri RM
        • Clavel MA
        • Mantovani F
        • Michelena HI
        • Pislaru S
        • Mahoney DW
        • Schaff HV.
        Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation.
        J Thorac Cardiovasc Surg. 2015; 150: 50-58
        • Tribouilloy C
        • Grigioni F
        • Avierinos JF
        • Barbieri A
        • Rusinaru D
        • Szymanski C
        • Ferlito M
        • Tafanelli L
        • Bursi F
        • Trojette F
        • Branzi A
        • Habib G
        • Modena MG
        • Enriquez-Sarano M
        • Investigators MIDA
        Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study.
        J Am Coll Cardiol. 2009; 54: 1961-1968
        • Tribouilloy C
        • Rusinaru D
        • Grigioni F
        • Michelena HI
        • Vanoverschelde JL
        • Avierinos JF
        • Barbieri A
        • Pislaru SV
        • Russo A
        • Pasquet A
        • Théron A
        • Szymanski C
        • Lévy F
        • Enriquez-Sarano M
        Mitral Regurgitation International Database (MIDA) Investigators. Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: a multicenter analysis.
        Circ Cardiovasc Imaging. 2014; 7: 363-370
        • Ringle Griguer A
        • Tribouilloy C
        • Truffier A
        • Castel AL
        • Delelis F
        • Levy F
        • Vincentelli A
        • Bohbot Y
        • Maréchaux S
        Clinical significance of ejection dynamics parameters in patients with aortic stenosis: an outcome study.
        J Am Soc Echocardiogr. 2018; 31 (e2): 551-560
        • Alhakak AS
        • Teerlink JR
        • Lindenfeld J
        • Böhm M
        • Rosano GMC
        • Biering-Sørensen T.
        The significance of left ventricular ejection time in heart failure with reduced ejection fraction.
        Eur J Heart Fail. 2021; 23: 541-551
        • Zoghbi WA
        • Adams D
        • Bonow RO
        • Enriquez-Sarano M
        • Foster E
        • Grayburn PA
        • Hahn RT
        • Han Y
        • Hung J
        • Lang RM
        • Little SH
        • Shah DJ
        • Shernan S
        • Thavendiranathan P
        • Thomas JD
        • Weissman NJ.
        Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance.
        J Am Soc Echocardiogr. 2017; 30: 303-371
        • Lancellotti P
        • Tribouilloy C
        • Hagendorff A
        • Popescu BA
        • Edvardsen T
        • Pierard LA
        • Badano L
        • Zamorano JL
        Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging.
        Eur Heart J Cardiovasc Imaging. 2013; 14: 611-644
        • Lang RM
        • Badano LP
        • Mor-Avi V
        • Afilalo J
        • Armstrong A
        • Ernande L
        • Flachskampf FA
        • Foster E
        • Goldstein SA
        • Kuznetsova T
        • Lancellotti P
        • Muraru D
        • Picard MH
        • Rietzschel ER
        • Rudski L
        • Spencer KT
        • Tsang W
        • Voigt JU.
        Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
        J Am Soc Echocardiogr. 2015; 28 (e14): 1-39
        • Austin PC.
        Absolute risk reductions and numbers needed to treat can be obtained from adjusted survival models for time-to-event outcomes.
        J Clin Epidemiol. 2010; 63: 46-55
        • Zhang Z
        • Ambrogi F
        • Bokov AF
        • Gu H
        • de Beurs E
        • Eskaf K.
        Estimate risk difference and number needed to treat in survival analysis.
        Ann Transl Med. 2018; 6: 120
        • Suri RM
        • Vanoverschelde JL
        • Grigioni F
        • Schaff HV
        • Tribouilloy C
        • Avierinos JF
        • Barbieri A
        • Pasquet A
        • Huebner M
        • Rusinaru D
        • Russo A
        • Michelena HI
        • Enriquez-Sarano M.
        Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets.
        JAMA. 2013; 310: 609-616
        • Kang DH
        • Park SJ
        • Sun BJ
        • Cho EJ
        • Kim DH
        • Yun SC
        • Song JM
        • Park SW
        • Chung CH
        • Song JK
        • Lee JW
        • Park PW.
        Early surgery versus conventional treatment for asymptomatic severe mitral regurgitation: a propensity analysis.
        J Am Coll Cardiol. 2014; 63: 2398-2407
        • Goldstone AB
        • Patrick WL
        • Cohen JE
        • Aribeana CN
        • Popat R
        • Woo YJ.
        Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis.
        Ann Cardiothorac Surg. 2015; 4: 220-229
        • Bonow RO
        • O'Gara PT
        • Adams DH
        • Badhwar V
        • Bavaria JE
        • Elmariah S
        • Hung JW
        • Lindenfeld J
        • Morris AA
        • Satpathy R
        • Whisenant B
        • Woo YJ
        2020 focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology solution set oversight committee.
        J Am Coll Cardiol. 2020; 75 ([published correction appears in J Am Coll Cardiol 2020;75:3000]): 2236-2270
        • Weissler AM
        • Harris WS
        • Schoenfeld CD.
        Systolic time intervals in heart failure in man.
        Circulation. 1968; 37: 149-159
        • Kitchiner DJ
        • Lewis BS
        • Gotsman MS.
        Systolic time intervals in mitral incompetence.
        Chest. 1973; 64: 711-718
        • Moskowitz RL
        • Wechsler BM.
        Left ventricular ejection time in aortic and mitral valve disease.
        Am J Cardiol. 1965; 15: 809-814
        • Wanderman KL
        • Goldberg MJ
        • Stack RS
        • Weissler AM.
        Left ventricular performance in mitral regurgitation assessed with systolic time intervals and echocardiography.
        Am J Cardiol. 1976; 38: 831-835
        • Grossman W
        • Jones D
        • McLaurin LP.
        Wall stress and patterns of hypertrophy in the human left ventricle.
        J Clin Invest. 1975; 56: 56-64
        • Gaasch WH
        • Meyer TE.
        Left ventricular response to mitral regurgitation: implications for management.
        Circulation. 2008; 118: 2298-2303
        • Dupuis M
        • Mahjoub H
        • Clavel MA
        • Côté N
        • Toubal O
        • Tastet L
        • Dumesnil JG
        • O'Connor K
        • Dahou A
        • Thébault C
        • Bélanger C
        • Beaudoin J
        • Arsenault M
        • Bernier M
        • Pibarot P
        Forward left ventricular ejection fraction: a simple risk marker in patients with primary mitral regurgitation.
        J Am Heart Assoc. 2017; 6e006309
        • Alhakak AS
        • Sengeløv M
        • Jørgensen PG
        • Bruun NE
        • Johnsen C
        • Abildgaard U
        • Iversen AZ
        • Hansen TF
        • Teerlink JR
        • Malik FI
        • Solomon SD
        • Gislason G
        • Biering-Sørensen T.
        Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fraction.
        Eur J Heart Fail. 2021; 23: 240-249
        • Migrino RQ
        • Mareedu RK
        • Eastwood D
        • Bowers M
        • Harmann L
        • Hari P.
        Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis.
        J Am Soc Echocardiogr. 2009; 22: 1396-1402
        • Sztrymf B
        • Günther S
        • Artaud-Macari E
        • Savale L
        • Jaïs X
        • Sitbon O
        • Simonneau G
        • Humbert M
        • Chemla D.
        Left ventricular ejection time in acute heart failure complicating precapillary pulmonary hypertension.
        Chest. 2013; 144: 1512-1520
        • Biering-Sørensen T
        • Querejeta Roca G
        • Hegde SM
        • Shah AM
        • Claggett B
        • Mosley Jr, TH
        • Butler Jr, KR
        • Solomon SD
        Left ventricular ejection time is an independent predictor of incident heart failure in a community-based cohort.
        Eur J Heart Fail. 2018; 20: 1106-1114